Nanhua Biotech announced that the cumulative closing price increase of the company's stock deviated by more than 20% for three consecutive trading days from September 22 to 24, 2026, which is an abnormal stock fluctuation. The company's stock price rose from 8.27 yuan to 13.73 yuan for six consecutive trading days from September 17 to 24, with a cumulative increase of 66.02%. It is characterized by excessive market sentiment and irrational speculation. After verification, the company had no important matters that should have been disclosed but not disclosed, and the controlling shareholders and actual controllers did not trade the company's shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.